During the past decade, Spectrum Health-Blodgett Campus conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 6 clinical trials were completed, i.e. on average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spectrum Health-Blodgett Campus" #1 sponsor was "SWOG Cancer Research Network" with 5 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "GOG Foundation" with 1 trials sponsored and "Gynecologic Oncology Group" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spectrum Health-Blodgett Campus" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Spectrum Health-Blodgett Campus" are "Breast Cancer" (2 trials), "Adenocarcinoma of the Colon" (1 trials), "Anal Cancer" (1 trials), "Burns" (1 trials) and "Cervical Adenocarcinoma" (1 trials). Many other conditions were trialed in "Spectrum Health-Blodgett Campus" in a lesser frequency.

Most popular intervention types in "Spectrum Health-Blodgett Campus" are "Drug" (12 trials), "Biological" (6 trials), "Other" (3 trials), "Procedure" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "cisplatin" (3 trials), "paclitaxel" (3 trials), "Carboplatin" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Spectrum Health-Blodgett Campus" are 9 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Spectrum Health-Blodgett Campus". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Spectrum Health-Blodgett Campus, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Spectrum Health-Blodgett Campus, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".